Silver Santé Study experts from several institutions and countries presented their work at this year’s prestigious Alzheimer’s Association International Conference (AAIC) in July.

The conference, which for the first time ever took place as a hybrid event with sessions being held virtually and in- person in Denver, is the largest and most influential international meeting dedicated to advancing dementia science. Each year, AAIC convenes the world’s leading basic science and clinical researchers, next-generation investigators, clinicians and the care research community to share research discoveries that will lead to methods of prevention and treatment and improvements in the diagnosis of Alzheimer’s disease.

Silver Santé Study researchers and Phd students, including those from the University of Caen, Inserm, and UCL in the UK participated in various sessions and presented posters of the study’s most recent findings during the five-day conference.

Project Coordinator, Dr Gaël Chételat, who was among those attending the conference, said: “As the world’s leading Alzheimer’s conference, the AAIC provided us with an invaluable opportunity to share and discuss our most recent findings including studies into the impact of COVID-19 on cognitive reserve and resilience, with the international scientific community.

“It was also extremely interesting to hear from other scientists involved in this important field of research.”